P

    PolyPid (PYPD)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $5.14
    +0.07 (+1.38%)

    Market Cap: $102.98M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    65%(17/26)
    Avg Surprise
    -99.06%

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$0.30
    Range$-0.40 - $1.02
    4 analysts
    EPS Revisions
    2
    0
    7d
    2
    1
    30d
    EPS Estimate Drift
    90d ago$-0.31-202.7%
    60d ago$-0.32-203.3%
    30d ago$-0.32-203.3%
    7d ago$0.30+0.0%
    Current$0.30
    Revenue Consensus
    $15M
    Range$0 - $30M
    4 analysts
    Dec 31, 2026
    EPS Consensus$-0.38
    Range$-1.17 - $0.47
    4 analysts
    Revenue Consensus
    $0
    Range$-15000000 - $15M
    4 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.38---
    Sep 26EST
    		-$0.30---
    Jun 26
    		$-0.35$-0.34-2.94%Miss+55.1%
    Mar 26
    		$-0.35$-0.43+18.60%Beat+50.0%
    Dec 25
    		$-0.41$-0.33-24.24%Miss+61.7%
    Sep 25
    		$-0.37$-0.52+28.85%Beat+69.7%
    Jun 25
    		$-0.78$-0.55-41.82%Miss+37.6%
    Mar 25
    		$-0.70$-0.82+14.63%Beat+48.9%
    Dec 24
    		$-1.07$-0.88-21.59%Miss+72.1%
    Sep 24
    		$-1.22$-1.00-22.00%Miss+64.1%
    Jun 24
    		$-1.25$-1.30+3.85%Beat+88.4%
    Mar 24
    		$-1.37$-1.41+2.84%Beat+83.7%
    Dec 23
    		$-3.84$-4.29+10.49%Beat+60.0%
    Sep 23
    		$-3.40$-4.43+23.25%Beat+76.4%
    Jun 23
    		$-10.80$-13.32+18.92%Beat+41.0%
    Mar 23
    		$-8.40$-4.80-75.00%Miss+55.6%
    Dec 22
    		$-9.60$-12.36+22.33%Beat+54.9%
    Sep 22
    		$-14.40$-16.22+11.22%Beat+9.4%
    Jun 22
    		$-18.30$-20.10+8.96%Beat-8.9%
    Mar 22
    		$-18.90$-18.92+0.11%Beat-34.0%
    Dec 21
    		$-21.30$-16.64-28.00%Miss-73.2%
    Sep 21
    		$-15.90$-18.83+15.56%Beat-51.4%
    Jun 21
    		$-16.80$-15.75-6.67%Miss+91.2%
    Mar 21
    		$-14.10$-15.00+6.00%Beat-4238.5%
    Dec 20
    		$-12.30$-15.23+19.24%Beat-280.8%
    Sep 20
    		$-10.50$-12.20+13.93%Beat-1120.9%
    Jun 20
    		$-191.10$-6.90-2669.57%Miss-
    Mar 20
    		$-0.33N/A+97.42%Beat-
    Dec 17
    		$-3.23$0.00N/AMiss-
    Sep 17
    		$-0.86$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-3.47EV/EBITDA-0.36x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-243.60%ROIC-505.05%
    Financial Health
    Debt/Equity0.24xInterest CoverageN/A
    Current Ratio1.35xQuick Ratio1.14x
    Trading Statistics
    Beta1.39Avg Volume144.31K
    52-Week High$5.7352-Week Low$3.06

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$5.04
    SMA 20$4.89
    SMA 50$4.82
    SMA 200$4.47
    EMA 10$5.03
    EMA 20$4.91
    EMA 50$4.79
    EMA 200$4.43

    MACD

    Line: 0.13Signal: 0.10Hist: 0.03

    ADX

    ADX: 15.4+DI: 20.7-DI: 15.6

    Aroon & PSAR

    Aroon Up92.0
    Aroon Down4.0
    PSAR$4.73

    Bollinger Bands

    Upper Band$5.29
    Lower Band$4.49
    %B Position1623%(Upper)
    Band Width0.82

    RSI (14-Day)

    Neutral
    59.6

    Momentum Oscillators

    Stoch %K81.4
    Stoch %D81.9
    Williams %R-14.3
    ROC (10d)7.8%
    Momentum0.37
    CCI (20d)83.8
    MFI (14d)70.4

    Volatility Measures

    ATR (14d)$0.26(5.1%)
    StdDev (20d)0.20
    Hist Vol33.5%(Moderate)

    Volume Flow

    VWAP$5.09
    OBV24.5M
    AD Line-17.4M
    CMF (20d)0.070

    Volume Metrics

    Avg Vol (20d)138.0K
    Vol Ratio0.4x(Low)
    VWMA (20d)$4.87

    Pivot Points

    R3$5.31
    R2$5.23
    R1$5.15
    Pivot Point$5.07
    S1$4.99
    S2$4.91
    S3$4.83

    Advanced Oscillators

    TSI13.42
    Ultimate Osc54.5
    KST88.17

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total RevenueN/A$0$0$0$0$0$0$0$0$0$0$0
    Cost of RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
    Gross ProfitN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
    Operating Expenses$-7,849,000$7.76M$-8,530,000$7.46M$9.40M$7.58M$8.22M$7.39M$6.12M$6.30M$6.00M$5.26M
    R&D$6.13M$5.76M$6.22M$5.26M$6.21M$6.12M$7.03M$5.97M$4.76M$5.05M$4.59M$3.81M
    SG&A$1.26M$1.59M$1.76M$1.77M$2.49M$1.17M$996,000$1.17M$1.10M$1.01M$1.22M$1.19M
    Operating Income$7.85M$-7,760,000$8.53M$-7,455,000$-9,403,000$-7,579,000$-8,221,000$-7,386,000$-6,121,000$-6,301,000$-5,999,000$-5,260,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$15.69M$0$24,000$0$521,000$678,000$286,000$354,000$171,000$140,000$348,000$319,000
    Income Before Tax$-7,843,000$-7,728,000$-8,554,000$-7,429,000$-9,924,000$-8,257,000$-8,507,000$-7,740,000$-6,292,000$-6,441,000$-6,347,000$-5,579,000
    Income Tax Expense$6,000$0$-81,000$22,000$53,000$11,000$13,000$20,000$2,000$7,000$9,000$25,000
    Net Income$-7,849,000$-7,728,000$-8,473,000$-7,451,000$-9,977,000$-8,268,000$-8,520,000$-7,760,000$-6,294,000$-6,448,000$-6,356,000$-5,604,000
    EBITDA$-7,484,500$-7,728,000$-8,124,500$-7,429,000$-9,403,000$-7,579,000$-8,221,000$-7,386,000$-6,121,000$-6,301,000$-5,999,000$-5,260,000
    EBIT$-7,849,000N/A$-8,530,000N/A$-9,403,000$-7,579,000$-8,221,000$-7,386,000$-6,344,276$-6,301,000$-6,042,812$-5,220,414
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about PYPD

    News

    PolyPid | 3: Initial statement of beneficial ownership of securities- Warshavsky Ori

    This document is an initial statement of beneficial ownership of securities for Warshavsky Ori regarding PolyPid. It signifies the first report detailing an individual's direct or indirect ownership of a company's shares, crucial for regulatory transparency.

    Moomoo•8/20/26•
    Neutral

    PolyPid | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

    This document is a 6-K filing by PolyPid, indicating it is a report of a foreign private issuer as per SEC rules 13a-16 and 15d-16. The content explicitly states "Document," implying the filing itself is the primary information being conveyed.

    Moomoo•8/20/26•
    Neutral

    AIGH Capital Management LLC Purchases Shares of 1,504,741 PolyPid Ltd. $PYPD

    AIGH Capital Management LLC recently acquired 1,504,741 shares of PolyPid Ltd. (NASDAQ:PYPD) for approximately $7.6 million, representing a 7.89% stake and making it their 24th largest holding. PolyPid reported better-than-expected quarterly earnings, with analysts predicting a full-year loss of $1.67 per share. Despite the current stock price, analysts have a "Moderate Buy" consensus with an average price target of $11.33.

    MarketBeat•8/17/26•
    Bullish

    PolyPid Ltd (PYPD) Stock News Today

    This article provides the latest news for PolyPid Ltd (PYPD) stock, including its current trading price, market cap, and recent earnings call highlights. The company's Q2 2026 earnings call focused on the D-PLEX100 Priority Review and the Azurity Deal. The stock is currently trading at $4.730, down 1.05%.

    TradingKey•8/14/26•
    Neutral

    PolyPid (PYPD) investors disclose up to 13.4% beneficial stake via complex structure

    A group of related investors, led by Xenia Venture Capital Limited, has filed an amended Schedule 13G/A for PolyPid Ltd. (PYPD), disclosing a beneficial ownership of up to 13.4% of the company's Ordinary Shares. The complex ownership structure involves Rodney Hodges, Geneva Holding Company (GHC) SA, Geneva Trust Company (GTC) SA, and Centaurus Investments Limited, with Hodges disclaiming day-to-day control. The filing details specific share and warrant holdings for each entity and confirms the total outstanding shares of PolyPid as of June 30, 2026.

    Stock Titan•8/13/26•
    Neutral

    Frequently Asked Questions About PYPD

    Does PYPD pay dividends?
    PolyPid (PYPD) does not currently pay a regular dividend.
    What is PYPD's market cap?
    PolyPid (PYPD) has a market capitalization of $102.98M with a current stock price of $5.14.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In